Protecting Lab Revenue: Genetic Testing Compliance & Unbundling Risks in 2026
- February 27, 2026
- Kimberly Chew , Husch Blackwell LLP
- Brian Flood , Husch Blackwell LLP
The laboratory industry is under heightened scrutiny in 2026, with federal regulators and contractors sharpening their focus on compliance in genetic testing, billing practices, and reimbursement reporting. Enforcement actions are on the rise, and recent government reports and settlements highlight the need for labs and those who advise them to stay vigilant, proactive, and informed. This article outlines the most significant trends for the lab community, including recent Department of Health and Human Services Office of Inspector General (OIG) findings, audit risks, enforcement actions, and practical compliance strategies.
ARTICLE TAGS
You must be logged in to access this content.